Home / FRX.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does FRX.TO make money? Does FRX.TO have pricing power? What's the Earnings Whisper? Will FRX.TO profit more as the business scales? What is FRX.TO's management track record? Is FRX.TO's current price justified?

Fennec Pharmaceuticals Inc.

CAD 17.1 +$6.69 (+64.27%)

TSX · 10 Sep 2026 20:10 UTC

Previous Close

CAD 17.1

Day Range

CAD 17.1 - CAD 17.1

Year Range

CAD 7.59CAD 17.64

Market Cap

594M

AVG Volume

1.05K

Trailing/Forward PE

-84.31/18.65

PEG ratio

-0.36

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Toronto Stock Exchange

Revenue (USD) · TTM

FRX.TO Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	59.39M
26 Q1	51.17M
25 Q4	44.85M
25 Q3	38.79M
25 Q2	33.3M
25 Q1	30.91M
24 Q4	47.54M
24 Q3	49.35M
24 Q2	48.89M
24 Q1	44.95M

Net Income (USD) · TTM

FRX.TO Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-3.69M
26 Q1	-8.81M
25 Q4	-10.18M
25 Q3	-6.94M
25 Q2	-12.04M
25 Q1	-14.44M
24 Q4	-436K
24 Q3	-1.13M
24 Q2	2.73M
24 Q1	2.84M

Operating Income (USD) · TTM

FRX.TO Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-1.63M
26 Q1	-6.1M
25 Q4	-6.79M
25 Q3	-4.66M
25 Q2	-9.68M
25 Q1	-11.98M
24 Q4	2.57M
24 Q3	1.68M
24 Q2	5.87M
24 Q1	6.24M

EBITDA (USD) · TTM

FRX.TO EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-1.07M
26 Q1	-5.36M
25 Q4	-6.14M
25 Q3	-3.71M
25 Q2	-8.39M
25 Q1	-10.34M
24 Q4	4.8M
24 Q3	3.73M
24 Q2	7.47M
24 Q1	7.34M

Cash Flows (USD) · TTM

FRX.TO Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-4.14M
26 Q1	-7.86M
25 Q4	-14.55M
25 Q3	-7.99M
25 Q2	-11.68M
25 Q1	-16.39M
24 Q4	26.98M
24 Q3	23.59M
24 Q2	23.04M
24 Q1	27.48M

EPS (USD) · TTM

FRX.TO EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.13
26 Q1	-0.3
25 Q4	-0.34
25 Q3	-0.25
25 Q2	-0.43
25 Q1	-0.52
24 Q4	-0.07
24 Q3	-0.1
24 Q2	0.04
24 Q1	0.03

Expenses (USD) · TTM

FRX.TO Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	57.28M
26 Q1	53.29M
25 Q4	47.85M
25 Q3	40.78M
25 Q2	39.61M
25 Q1	39.89M
24 Q4	41.79M
24 Q3	44.46M
24 Q2	40.85M
24 Q1	37M

Shares Outstanding (USD) · TTM

FRX.TO Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-5.73M
26 Q1	-7.22M
25 Q4	-7.02M
25 Q3	-5.61M
25 Q2	-5.22M
25 Q1	-4.56M
24 Q4	-4.94M
24 Q3	-4.67M
24 Q2	-3.7M
24 Q1	-5.38M

PE Ratio

FRX.TO PE Ratio by quarter
Period	PE Ratio
Dec 24	61.86
Dec 24	59.53
Dec 24	60.89
Dec 24	61.65
Nov 24	60.53
Nov 24	52.51
Nov 24	40.04
Nov 24	42.93
Nov 24	43.52
Oct 24	42.19
Oct 24	46.66
Oct 24	41.79
Oct 24	46.04
Sep 24	49.41
Sep 24	49.7
Sep 24	51.67
Sep 24	50.04
Aug 24	52.12
Aug 24	54.72
Aug 24	54.04
Aug 24	55.08
Aug 24	54.71
Jul 24	63.45
Jul 24	61.24
Jul 24	60.75
Jul 24	55.56

Free Cash Flow Yield

FRX.TO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-1.85%
Sep 26	-1.82%
Aug 26	-1.87%
Aug 26	-2.03%
Aug 26	-1.87%
Aug 26	-1.99%
Jul 26	-2.32%
Jul 26	-2.27%
Jul 26	-2.26%
Jul 26	-2.24%
Jul 26	-2.12%
Jun 26	-4.35%
Jun 26	-5.21%
Jun 26	-5.27%
Jun 26	-5.12%
May 26	-4.71%
May 26	-4.71%
May 26	-4.82%
May 26	-6.62%
May 26	-7.15%
Apr 26	-6.82%
Apr 26	-6.8%
Apr 26	-7.98%
Apr 26	-7.28%
Mar 26	-4.77%
Mar 26	-3.89%
Mar 26	-3.66%
Mar 26	-3.75%
Feb 26	-3.35%
Feb 26	-3.26%
Feb 26	-3.71%
Feb 26	-3.63%
Jan 26	-3.82%
Jan 26	-3.75%
Jan 26	-3.79%
Jan 26	-3.67%
Jan 26	-3.78%
Dec 25	-3.68%
Dec 25	-3.8%
Dec 25	-3.72%
Dec 25	-3.75%
Nov 25	-3.58%
Nov 25	-3.59%
Nov 25	-3.6%
Nov 25	-5.07%
Oct 25	-5.1%
Oct 25	-4.66%
Oct 25	-5.11%
Oct 25	-4.81%
Oct 25	-4.28%
Sep 25	-6.57%
Sep 25	-6.86%
Sep 25	-6.44%
Sep 25	-6.62%
Aug 25	-6.6%
Aug 25	-6.88%
Aug 25	-6.93%
Aug 25	-7.17%
Aug 25	-7.44%
Jul 25	-6.79%
Jul 25	-7%
Jul 25	-6.72%
Jul 25	-6.64%
Jun 25	11.9%
Jun 25	12.53%
Jun 25	12.4%
Jun 25	11.41%
May 25	12%
May 25	12.1%
May 25	14.44%
May 25	15.14%
May 25	15.87%
Apr 25	19.22%
Apr 25	19.2%
Apr 25	19.32%
Apr 25	18.76%
Mar 25	13.43%
Mar 25	12.96%
Mar 25	13.1%
Mar 25	12.64%
Feb 25	12.32%
Feb 25	12.93%
Feb 25	12.51%
Feb 25	13.69%
Jan 25	13.5%
Jan 25	13.77%
Jan 25	15.68%
Jan 25	14.51%
Jan 25	14.14%
Dec 24	13.62%
Dec 24	14.15%
Dec 24	13.83%
Dec 24	13.66%
Nov 24	13.92%
Nov 24	16.04%
Nov 24	21.04%
Nov 24	19.62%
Nov 24	19.36%
Oct 24	19.97%
Oct 24	18.05%

Price to Sales

FRX.TO Price to Sales by quarter
Period	Price to Sales
Sep 26	8.31
Sep 26	8.45
Aug 26	8.21
Aug 26	7.55
Aug 26	8.23
Aug 26	7.71
Jul 26	6.63
Jul 26	6.77
Jul 26	6.81
Jul 26	6.88
Jul 26	7.24
Jun 26	7.47
Jun 26	6.23
Jun 26	6.16
Jun 26	6.34
May 26	6.89
May 26	6.89
May 26	6.73
May 26	4.9
May 26	4.54
Apr 26	4.76
Apr 26	4.77
Apr 26	4.07
Apr 26	4.46
Mar 26	4.31
Mar 26	5.29
Mar 26	5.62
Mar 26	5.49
Feb 26	6.14
Feb 26	6.32
Feb 26	5.55
Feb 26	5.68
Jan 26	5.39
Jan 26	5.49
Jan 26	5.43
Jan 26	5.61
Jan 26	5.45
Dec 25	5.59
Dec 25	5.41
Dec 25	5.53
Dec 25	5.49
Nov 25	5.75
Nov 25	5.74
Nov 25	5.72
Nov 25	6.92
Oct 25	6.88
Oct 25	7.52
Oct 25	6.87
Oct 25	7.3
Oct 25	8.19
Sep 25	8.07
Sep 25	7.73
Sep 25	8.24
Sep 25	8
Aug 25	8.03
Aug 25	7.71
Aug 25	7.65
Aug 25	7.39
Aug 25	7.12
Jul 25	7.81
Jul 25	7.57
Jul 25	7.89
Jul 25	7.98
Jun 25	4.77
Jun 25	4.53
Jun 25	4.58
Jun 25	4.98
May 25	4.73
May 25	4.69
May 25	3.93
May 25	3.75
May 25	3.58
Apr 25	2.95
Apr 25	2.96
Apr 25	2.94
Apr 25	3.03
Mar 25	3.56
Mar 25	3.69
Mar 25	3.65
Mar 25	3.78
Feb 25	3.88
Feb 25	3.7
Feb 25	3.82
Feb 25	3.49
Jan 25	3.54
Jan 25	3.47
Jan 25	3.05
Jan 25	3.3
Jan 25	3.38
Dec 24	3.46
Dec 24	3.33
Dec 24	3.41
Dec 24	3.45
Nov 24	3.39
Nov 24	2.94
Nov 24	2.24
Nov 24	2.4
Nov 24	2.43
Oct 24	2.36
Oct 24	2.61

EV/EBITDA

FRX.TO EV/EBITDA by quarter
Period	EV/EBITDA
Jun 25	45.72
Jun 25	43.37
Jun 25	43.83
Jun 25	47.78
May 25	45.36
May 25	44.97
May 25	37.41
May 25	35.62
May 25	33.91
Apr 25	27.74
Apr 25	27.77
Apr 25	27.59
Apr 25	28.45
Mar 25	44.91
Mar 25	46.62
Mar 25	46.09
Mar 25	47.85
Feb 25	49.14
Feb 25	46.72
Feb 25	48.39
Feb 25	44.02
Jan 25	44.68
Jan 25	43.74
Jan 25	38.14
Jan 25	41.42
Jan 25	42.55
Dec 24	21.12
Dec 24	20.27
Dec 24	20.77
Dec 24	21.05
Nov 24	20.64
Nov 24	17.7
Nov 24	13.14
Nov 24	14.2
Nov 24	14.42
Oct 24	13.93
Oct 24	15.56
Oct 24	13.78
Oct 24	15.34
Sep 24	16.45
Sep 24	16.56
Sep 24	17.32
Sep 24	16.69
Aug 24	17.5
Aug 24	18.5
Aug 24	18.24
Aug 24	18.64
Aug 24	18.5
Jul 24	21.89
Jul 24	21.03
Jul 24	20.84
Jul 24	18.83

Price/Operating Cashflow

FRX.TO Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Jun 25	8.4
Jun 25	7.98
Jun 25	8.07
Jun 25	8.77
May 25	8.34
May 25	8.27
May 25	6.92
May 25	6.61
May 25	6.3
Apr 25	5.2
Apr 25	5.21
Apr 25	5.18
Apr 25	5.33
Mar 25	7.45
Mar 25	7.72
Mar 25	7.63
Mar 25	7.91
Feb 25	8.11
Feb 25	7.73
Feb 25	8
Feb 25	7.31
Jan 25	7.41
Jan 25	7.26
Jan 25	6.38
Jan 25	6.89
Jan 25	7.07
Dec 24	7.34
Dec 24	7.07
Dec 24	7.23
Dec 24	7.32
Nov 24	7.19
Nov 24	6.23
Nov 24	4.75
Nov 24	5.1
Nov 24	5.17
Oct 24	5.01
Oct 24	5.54
Oct 24	4.96
Oct 24	5.46
Sep 24	5.11
Sep 24	5.14
Sep 24	5.35
Sep 24	5.18
Aug 24	5.39
Aug 24	5.66
Aug 24	5.59
Aug 24	5.7
Aug 24	5.66
Jul 24	6.57
Jul 24	6.34
Jul 24	6.29
Jul 24	5.75

Price to Book

FRX.TO Price to Book by quarter
Period	Price to Book
Sep 26	11.32
Sep 26	11.51
Aug 26	11.17
Aug 26	10.28
Aug 26	11.2
Aug 26	10.5
Jul 26	9.03
Jul 26	9.22
Jul 26	9.27
Jul 26	9.36
Jul 26	9.85
Jun 26	9.55
Jun 26	7.98
Jun 26	7.88
Jun 26	8.12
May 26	8.82
May 26	8.81
May 26	8.61
May 26	6.28
May 26	5.81
Apr 26	6.09
Apr 26	6.11
Apr 26	5.21
Apr 26	5.71
Sep 24	46.62
Sep 24	46.9
Sep 24	48.75
Sep 24	47.21
Aug 24	49.18
Aug 24	51.63
Aug 24	50.99
Aug 24	51.97
Aug 24	51.63
Jul 24	59.87
Jul 24	57.78
Jul 24	57.32
Jul 24	52.43
Mar 23	70.49
Mar 23	76.63
Mar 23	85.09
Mar 23	85.17
Feb 23	83.5
Feb 23	87.79
Feb 23	90.53
Feb 23	91.25
Jan 23	89.93
Jan 23	92.32
Jan 23	100.2
Jan 23	92.14
Dec 22	90.02
Dec 22	30.4
Dec 22	29.84
Dec 22	29.2
Dec 22	29.41
Nov 22	29.19
Nov 22	26.21
Nov 22	24.49
Nov 22	25.77
Oct 22	25.79
Oct 22	25.35
Oct 22	24.17
Oct 22	23.9
Sep 22	24.6
Sep 22	16.12
Sep 22	14.06
Sep 22	15.78
Sep 22	15.43
Aug 22	13.28
Aug 22	13.53
Aug 22	14.3
Aug 22	13.8
Jul 22	14.34
Jul 22	14.4
Jul 22	13.94
Jul 22	13.17
Jun 22	11.73
Jun 22	9.3
Jun 22	9.18
Jun 22	8.95
Jun 22	9.5
May 22	8.69
May 22	9.51
May 22	8.9
May 22	9.58
Apr 22	10.26
Apr 22	9.78
Apr 22	10.48
Apr 22	10.52
Apr 22	9.62
Mar 22	8.04
Mar 22	7.51
Mar 22	7.42
Mar 22	7.04
Feb 22	7.5
Feb 22	6.57
Feb 22	7.08
Feb 22	6.37
Jan 22	5.97
Jan 22	6.34
Jan 22	6.2

No video analysis for this stock yet. Request one from our team.

AI Analysis

Fennec Pharmaceuticals Inc.

Video analysis: FRX.TO

Similar companies